• 1. Emergence of cationic polyamine dendrimersomes: design, stimuli sensitivity and potential biomedical applications
  Partha Laskar,Christine Dufès Nanoscale Adv., 2021,3, 6007-6026
• 2. Excitation dependent bidirectional electron transfer in phthalocyanine-functionalised MoS2 nanosheets?
  Christopher J. Harrison,Kyle J. Berean,Enrico Della Gaspera,Jian Zhen Ou,Richard B. Kaner,Kourosh Kalantar-zadeh,Torben Daeneke Nanoscale, 2016,8, 16276-16283
• 3. Fast-pulsing NMR techniques for the detection of weak interactions: successful natural abundance probe of hydrogen bonds in peptides?
  Amandine Altmayer-Henzien,Valérie Declerck,David J. Aitken,Ewen Lescop,Denis Merlet,Jonathan Farjon Org. Biomol. Chem., 2013,11, 7611-7615
• 4. Evolution in surface coverage of CH3NH3PbI3?XClXvia heat assisted solvent vapour treatment and their effects on photovoltaic performance of devices
  Dhirendra K. Chaudhary,Pramendra Kumar,Lokendra Kumar RSC Adv., 2016,6, 94731-94738
• 5. Fc microparticles can modulate the physical extent and magnitude of complement activity?
  David White,Sean R. Stowell Biomater. Sci., 2017,5, 463-474

Introduction to 5-Amino-3-bromo-2-(N,N-diethylamino)pyridine (CAS No: 1216027-34-7)

5-Amino-3-bromo-2-(N,N-diethylamino)pyridine, identified by its Chemical Abstracts Service (CAS) number 1216027-34-7, is a significant compound in the realm of pharmaceutical and biochemical research. This heterocyclic organic molecule belongs to the pyridine family, characterized by a nitrogen-containing aromatic ring. The presence of multiple functional groups—specifically an amino group, a bromo substituent, and a N,N-diethylamino moiety—makes it a versatile intermediate in synthetic chemistry and drug development.

The compound's structure imparts unique electronic and steric properties, which are highly valuable in medicinal chemistry. The 5-amino group provides a nucleophilic site for further functionalization, while the 3-bromo substituent acts as a versatile handle for cross-coupling reactions, such as Suzuki or Buchwald-Hartwig couplings. Additionally, the N,N-diethylamino group enhances lipophilicity and potential bioavailability, making it an attractive scaffold for pharmacophore design.

In recent years, 5-Amino-3-bromo-2-(N,N-diethylamino)pyridine has garnered attention in the development of novel therapeutic agents. Its structural motifs are reminiscent of established bioactive molecules, suggesting potential applications in treating neurological disorders, infectious diseases, and cancer. For instance, pyridine derivatives have been extensively studied for their role as kinase inhibitors and antiviral agents.

One of the most compelling aspects of this compound is its utility in fragment-based drug discovery. Researchers have leveraged its scaffold to identify lead compounds with promising biological activity. The bromo group, in particular, facilitates modular construction through transition-metal-catalyzed reactions, enabling rapid diversification of the molecular library. This approach has been instrumental in accelerating the discovery of drugs targeting complex diseases.

The N,N-diethylamino side chain not only improves solubility but also modulates receptor binding affinity. This feature is particularly relevant in designing molecules that require precise interaction with biological targets. Recent studies have demonstrated its incorporation into small-molecule inhibitors that exhibit high selectivity for protein kinases involved in cancer progression.

Moreover, the 5-amino group serves as a critical site for post-synthetic modifications. Through reductive amination or diazotization reactions, it can be transformed into various derivatives with tailored properties. Such modifications have been employed to enhance metabolic stability or improve pharmacokinetic profiles of candidate drugs.

From a synthetic chemistry perspective, 5-Amino-3-bromo-2-(N,N-diethylamino)pyridine exemplifies an ideal building block due to its balance of reactivity and stability. It can be easily accessed via multi-step synthetic routes involving halogenation and amination strategies. The compound's well-documented synthetic protocols make it accessible to both academic and industrial researchers, fostering innovation across multiple disciplines.

Recent advancements in computational chemistry have further highlighted the potential of this compound. Molecular modeling studies suggest that derivatives of 5-Amino-3-bromo-2-(N,N-diethylamino)pyridine may interact effectively with specific binding pockets on target proteins. These insights have guided experimental efforts toward optimizing potency and selectivity.

In clinical research, the compound has been explored as part of larger drug candidates designed to address unmet medical needs. While no marketed drugs are currently based on this exact structure, preclinical data indicate its promise as a starting point for further development. The ability to modify its core scaffold allows medicinal chemists to fine-tune properties such as solubility, permeability, and toxicity.

The versatility of 5-Amino-3-bromo-2-(N,N-diethylamino)pyridine extends beyond pharmaceutical applications. It has found utility in materials science as well, particularly in designing organic semiconductors and ligands for catalytic systems. Its ability to participate in π-stacking interactions makes it valuable for constructing supramolecular assemblies with specific functions.

As research continues to evolve, the demand for high-quality intermediates like 5-Amino-3-bromo-2-(N,N-diethylamino)pyridine is expected to grow. The compound's well-characterized properties and synthetic accessibility position it as a cornerstone in modern drug discovery pipelines. Collaborative efforts between chemists and biologists will likely uncover new applications that further underscore its importance.

In conclusion,5-Amino-3-bromo-2-(N,N-diethylamino)pyridine (CAS No: 1216027-34-7) represents a fascinating example of how structural complexity can be leveraged to develop innovative solutions in medicine and technology. Its multifaceted utility underscores the interconnectedness of chemical synthesis and biological function—a testament to the power of interdisciplinary research.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)